Ornament2.png

Ranifin

Ranitidine

Short Description

RANIFIN is a H2 receptor antagonist, used as the hydrochloride salt to inhibitgastric acid secretion in the treatment of gastric and duodenal ulcer, gastroesophageal reflux disease, and conditions that cause gastric hypersecretion.

Indications

Intravenous

Stress ulceration of upper gastrointestinal tract

Adult: 50 mg by slow IV inj as priming dose followed by 0.125-0.25 mg/kg/hr as continuous IV infusion then transfer to oral dose of 150 mg bid once oral feeding is resumed. Child: 1 mg/kg (max: 50 mg) as slow IV inj over at least 2 min 6-8 hrly or 0.125-0.25 mg/kg/hr as continuous infusion.

Hypersecretory conditions

Adult: Initially, 1 mg/kg/hr, may increase by increments of 0.5 mg/kg/hr beginning after 4 hr if necessary.

Specification

Injection

RANIFIN injection 50 mg/2ml

  • Each ml contains : Ranitidine 25 mg

  • Box, 5 ampoules @ 2 ml

multi-gyn.png

Gastrointestinal & Hepatobiliary Systems Product